CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
Since its discovery in 2012, CRISPR Cas9 has been tried as a direct treatment approach to
correct the causative gene mutation and establish animal models in neurodegenerative …
correct the causative gene mutation and establish animal models in neurodegenerative …
CRISPR and iPSCs: recent developments and future perspectives in neurodegenerative disease modelling, research, and therapeutics
T Sen, RP Thummer - Neurotoxicity Research, 2022 - Springer
Neurodegenerative diseases are prominent causes of pain, suffering, and death worldwide.
Traditional approaches modelling neurodegenerative diseases are deficient, and therefore …
Traditional approaches modelling neurodegenerative diseases are deficient, and therefore …
Mitochondria: powering the innate immune response to Mycobacterium tuberculosis infection
KL Patrick, RO Watson - Infection and immunity, 2021 - Am Soc Microbiol
Within the last decade, we have learned that damaged mitochondria activate many of the
same innate immune pathways that evolved to sense and respond to intracellular …
same innate immune pathways that evolved to sense and respond to intracellular …
Cell reprogramming therapy for Parkinson's disease
W Dong, S Liu, S Li, Z Wang - Neural Regeneration Research, 2023 - journals.lww.com
Parkinson's disease is typically characterized by the progressive loss of dopaminergic
neurons in the substantia nigra pars compacta. Many studies have been performed based …
neurons in the substantia nigra pars compacta. Many studies have been performed based …
细胞重编程治疗帕金森病
W Dong, S Liu, S Li, Z Wang - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
由于帕金森病的典型病理改变是黑质致密部中多巴胺能神经元的退行性变,
许多研究都是基于补充丢失的多巴胺能神经元来治疗帕金森病. 针对细胞替代治疗的策略最初 …
许多研究都是基于补充丢失的多巴胺能神经元来治疗帕金森病. 针对细胞替代治疗的策略最初 …
[图书][B] The Role Of The Parkinson's Disease-Related Protein LRRK2 In Autophagy And Calcium Signalling In Cellular Models
S Azeggagh - 2020 - search.proquest.com
Parkinson's disease (PD) is the second most common neurodegenerative disease
worldwide, affecting 3% of individuals of> 75 years of age. The disease is relentless and …
worldwide, affecting 3% of individuals of> 75 years of age. The disease is relentless and …
[HTML][HTML] Stem Cells Applications in Therapeutics and Site-Specific Genome Editing Through CRISPR Cas9 System
Stem cells are immature cells that have ability to differentiate into all specific and mature
cells in body. The two main characteristics of stem cells are self-renewable and ability to …
cells in body. The two main characteristics of stem cells are self-renewable and ability to …